相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of berberine in patients with type 2 diabetes mellitus
Jun Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Comparison of topological, shape, and docking methods in virtual screening
Georgia B. McGaughey et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors
Thomas Luebbers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Adapting the GLP-1-Signaling System to the Treatment of Type 2 Diabetes
Teresa Salvatore et al.
CURRENT DIABETES REVIEWS (2007)
Molecular recognition of ligands in dipeptidyl peptidase IV
Bernd Kuhn et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors
Zhonghua Pei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Berberine potently inhibits protein tyrosine phosphatase 1B: Investigation by docking simulation and experimental validation
Yasser Bustanji et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2006)
Dipeptidyl peptidase IV inhibitors: A promising new therapeutic approach for the management of type 2 diabetes
CF Deacon et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Berberine synergy with amphotericin B against disseminated candidiasis in mice
Y Han et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes
B Ahrén et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Evaluation of docking performance: Comparative data on docking algorithms
M Kontoyianni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The anti-inflammatory potential of berberine in vitro and in vivo
CL Kuo et al.
CANCER LETTERS (2004)
Dipeptidyl peptidase IV inhibitors for the treatment of diabetes
AE Weber
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes
MA Nauck et al.
DIABETES (2004)
Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects
JJ Meier et al.
DIABETES (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
PL Brubaker et al.
ENDOCRINOLOGY (2004)
Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: Interaction with drugs acting at 5-HT receptors
WH Peng et al.
LIFE SCIENCES (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla
ML Freile et al.
FITOTERAPIA (2003)
Enhancing incretin action for the treatment of type 2 diabetes
DJ Drucker
DIABETES CARE (2003)
Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy
Y Hong et al.
LIFE SCIENCES (2003)
Dipeptidyl peptidase IV inhibitor treatment stimulates β-cell survival and islet neogenesis in streptozotocin-induced diabetic rats
JA Pospisilik et al.
DIABETES (2003)
Effects of berberine on glucose metabolism in vitro
J Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients
T Vilsboll et al.
DIABETOLOGIA (2002)
Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics
JD Scott et al.
CHEMICAL REVIEWS (2002)
Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats
FC Lynn et al.
DIABETES (2001)
New perspectives into the molecular pathogenesis and treatment of Type 2 diabetes
AR Saltiel
CELL (2001)
No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose
T Vilsboll et al.
DIABETIC MEDICINE (2001)
Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations
C Bissantz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Synergy in a medicinal plant:: Antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor
FR Stermitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
